======= GALNS ======= == Gene Information == * **Official Symbol**: GALNS * **Official Name**: galactosamine (N-acetyl)-6-sulfatase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2588|2588]] * **UniProt**: [[https://www.uniprot.org/uniprot/P34059|P34059]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GALNS&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GALNS|Open PubMed]] * **OMIM**: [[https://omim.org/entry/612222|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes N-acetylgalactosamine-6-sulfatase which is a lysosomal exohydrolase required for the degradation of the glycosaminoglycans, keratan sulfate, and chondroitin 6-sulfate. Sequence alterations including point, missense and nonsense mutations, as well as those that affect splicing, result in a deficiency of this enzyme. Deficiencies of this enzyme lead to Morquio A syndrome, a lysosomal storage disorder. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: N/A |Phosphodiest| |Sulfatase| |N-acetylgalactosamine-6-sulfatase activity| |N-acetylgalactosamine-4-sulfatase activity| |sulfuric ester hydrolase activity| |keratan sulfate catabolic process| |arylsulfatase activity| |keratan sulfate metabolic process| |sulfur compound catabolic process| |glycosaminoglycan catabolic process| |aminoglycan catabolic process| |azurophil granule lumen| |lysosomal lumen| |mucopolysaccharide metabolic process| |glycosaminoglycan metabolic process| |aminoglycan metabolic process| |carbohydrate derivative catabolic process| |sulfur compound metabolic process| |neutrophil degranulation| |neutrophil activation involved in immune response| |neutrophil mediated immunity| |neutrophil activation| |granulocyte activation| |leukocyte degranulation| |myeloid leukocyte mediated immunity| |myeloid cell activation involved in immune response| |myeloid leukocyte activation| |leukocyte activation involved in immune response| |cell activation involved in immune response| |regulated exocytosis| |leukocyte mediated immunity| |exocytosis| |leukocyte activation| |oxoacid metabolic process| |secretion by cell| |organic acid metabolic process| |carbohydrate derivative metabolic process| |export from cell| |macromolecule catabolic process| |organonitrogen compound catabolic process| |cell activation| |immune effector process| |secretion| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| |immune response| |extracellular region| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|1.94| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6377 * **Expression level (log2 read counts)**: 4.43 {{:chemogenomics:nalm6 dist.png?nolink |}}